Search Results - "ATTMAN, Per Ola"

The low risk for early renal damage during lithium treatment has not changed over time by Golic, Mihaela, Aiff, Harald, Attman, Per-Ola, Ramsauer, Bernd, Schön, Staffan, Steingrimsson, Steinn, Svedlund, Jan

“…Background: Modern lithium management guidelines were introduced to improve the renal prognosis of lithium patients. Aims: To examine whether prospects for…”
Get full text

Starting lithium in patients with compromised renal function – is it wise? by Golic, Mihaela, Aiff, Harald, Attman, Per-Ola, Ramsauer, Bernd, Schön, Staffan, Steingrimsson, Steinn, Svedlund, Jan

“…Background: Little is known of the risks involved for patients who, at the start of lithium treatment, already have compromised renal function. Aims: To assess…”
Get full text

Compliance with the safety guidelines for long-term lithium treatment in Sweden by Golic, Mihaela, Aiff, Harald, Attman, Per-Ola, Ramsauer, Bernd, Schön, Staffan, Svedlund, Jan

“…Background: Lithium has been used for more than 50 years and guidelines for treatment monitoring have been documented in Sweden since the beginning of the…”
Get full text

Lifetime risk of severe kidney disease in lithium-treated patients: a retrospective study by Golic, Mihaela, Aiff, Harald, Attman, Per-Ola, Ramsauer, Bernd, Schön, Staffan, Steingrimsson, Steinn, Svedlund, Jan

“…Background Lithium is an essential psychopharmaceutical, yet side effects and concerns about severe renal function impairment limit its usage. Aims Our…”
Get full text

Oxidative stress and inflammation in renal patients and healthy subjects by Lee, Diana M, Jackson, Kenneth W, Knowlton, Nicholas, Wages, Joshua, Alaupovic, Petar, Samuelsson, Ola, Saeed, Aso, Centola, Michael, Attman, Per-Ola

“…The first goal of this study was to measure the oxidative stress (OS) and relate it to lipoprotein variables in 35 renal patients before dialysis (CKD), 37 on…”
Get full text

Renal failure occurs in chronic lithium treatment but is uncommon by Bendz, Hans, Schön, Staffan, Attman, Per-Ola, Aurell, Mattias

“…We sought to establish the prevalence of lithium-induced end-stage renal disease in two regions of Sweden with 2.7 million inhabitants corresponding to about…”
Get full text

Dialysis modalities and dyslipidemia by Attman, Per-Ola, Samuelsson, Ola, Johansson, Ann-Cathrine, Moberly, James B., Alaupovic, Petar

“…Dialysis modalities and dyslipidemia. Progressive renal failure is accompanied by dyslipidemia, which is reflected in an abnormal apolipoprotein profile. It is…”
Get full text

A practical approach to low protein diets in Sweden- 45 years of clinical use by Eyre, Sintra, Faxén-Irving, Gerd, Attman, Per-Ola, Evans, Marie, Windahl, Karin, Wegener, Sigrid, Andersén, Charlotte, Nykvist-Raanaes, Karin, Einemo, Sara, Carrero, Juan-Jesus

“…This review provides an overview of the development, implementation and practise of low protein diets (LPD) in Sweden. While the current practice is discussed…”
Get full text

Cardiovascular comorbidity increases the risk for renal failure during prophylactic lithium treatment by Aiff, Harald, Attman, Per-Ola, Ramsauer, Bernd, Schön, Staffan, Svedlund, Jan

“…•Somatic comorbidity seem to play a role for kidney failure during lithium treatment.•Cardiovascular disease was the most prominent risk factor in this…”
Get full text

End-stage renal disease associated with prophylactic lithium treatment by Aiff, Harald, Attman, Per-Ola, Aurell, Mattias, Bendz, Hans, Schön, Staffan, Svedlund, Jan

“…Abstract The primary aim of this study was to estimate the prevalence of lithium associated end-stage renal disease (ESRD) and to compare the relative risk of…”
Get full text

Effects of 10 to 30 years of lithium treatment on kidney function by Aiff, Harald, Attman, Per-Ola, Aurell, Mattias, Bendz, Hans, Ramsauer, Bernd, Schön, Staffan, Svedlund, Jan

“…Long-term lithium treatment is associated with end-stage renal disease, but there is little evidence of a clinically significant reduction in renal function in…”
Get full text

Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency by Lee, Diana M., Knight-Gibson, Carolyn, Samuelsson, Ola, Attman, Per-Ola, Wang, Chi-Sun, Alaupovic, Petar

“…Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency Increased concentrations of very low- (VLDL) and intermediate-density…”
Get full text

Protein Restriction and Body Composition in Renal Disease by Eyre, Sintra, RD, Attman, Per-Ola, MD, PhD

“…Objective To study the effect of low-protein diet (LPD) on body composition (BC). Study Design A systematic review of the literature investigating BC during…”
Get full text

Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia by Attman, Per-Ola

Get full text

Dyslipidemia of kidney disease by Attman, Per-Ola, Samuelsson, Ola

“…Chronic kidney disease is associated with specific alterations of lipoprotein metabolism that may be linked to accelerated atherosclerosis and cardiovascular…”
Get full text

The impact of modern treatment principles may have eliminated lithium-induced renal failure by Aiff, Harald, Attman, Per-Ola, Aurell, Mattias, Bendz, Hans, Schön, Staffan, Svedlund, Jan

“…We have previously shown that lithium can cause end-stage renal disease (ESRD): however, this serious side-effect of lithium in prophylactic treatment of mood…”
Get full text

Positive Effects of Protein Restriction in Patients With Chronic Kidney Disease by Eyre, Sintra, RD, Attman, Per-Ola, MD, PhD, Haraldsson, Börje, MD, PhD

“…Objectives The potential benefit or harm of low-protein diets (LPDs) for patients with chronic kidney disease has been debated. This study sought to…”
Get full text

Reply to Letter to the Editor by Aiff, Harald, Attman, Per-Ola, Bendz, Hans, Ramsauer, Bernd, Schön, Staffan, Svedlund, Jan

Get full text

The effect of decreasing renal function on lipoprotein profiles by Attman, Per-Ola, Samuelsson, Ola, Alaupovic, Petar

“…Background. Progressive chronic kidney disease (CKD) is accompanied by dyslipidemia that is characterized by increased concentrations of intact and partially…”
Get full text

Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia by Attman, Per-Ola, Ottosson, Pia, Samuelsson, Ola, Eriksson, Ulf G., Eriksson-Lepkowska, Maria, Fager, Gunnar

“…Background. This study assessed the feasibility of replacing intravenous (i.v.) dalteparin with the direct thrombin inhibitor (DTI) melagatran administered via…”
Get full text